---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-046167"
form_type: "8-K"
ticker: "ACXP"
cik: "0001736243"
company_name: "Acurx Pharmaceuticals, Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T04:57:52.700106+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Acurx Pharmaceuticals secures up to $12M equity line from Lincoln Park Capital

## Summary
- Lincoln Park committed to purchase up to $12M in common stock over 24 months.
- Regular purchases up to 60k shares/day (90k if stock ≥$2, 120k if ≥$3).
- Purchase price set at 97% of lowest of day's low or avg of three lowest closes in prior 10 days.
- Company issued 899,258 commitment shares to Lincoln Park as consideration.
- Proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001104659-25-046167
- form_type: 8-K
- ticker: ACXP
- cik: 0001736243
- company_name: Acurx Pharmaceuticals, Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1736243/000110465925046167/0001104659-25-046167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1736243/000110465925046167/tm2514277d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-046167
- JSON: https://secwatch.observer/filing/0001104659-25-046167.json
- Plain text: https://secwatch.observer/filing/0001104659-25-046167.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.